Abstract: The present disclosure provides a satellite system with orbital debris avoidance. In one embodiment, the satellite system includes debris sensor circuitry to scan orbital debris items in an orbital debris field; and sensor controller circuitry to determine a search window within the orbital debris field based on, at least, uncertainties associated with a velocity of the satellite (Vsatellite) and uncertainties associated with a velocity of at least one debris item (Vdebris), the sensor controller circuitry also to control the debris sensor circuitry to detect the at least one debris item within the search window.

Abstract: A method for access and mobility policy control in a communications network, the method comprising receiving at a first policy control entity for handling UE policies from a network node a notification including access and mobility policy data for a user equipment, the notification further including an application identifier or a packet flow descriptor to which the access and mobility policy data applies; obtaining at the first policy control entity PDU session information for the user equipment relative to the application identifier or the packet flow descriptor, particularly wherein the PDU session information is at least one of an application start/stop event, an out of credit event, a reallocation of credit event or a usage report; and modifying at least one access and mobility policy at the first policy control entity based on the obtained PDU session information. The network node may be a user data repository.

Abstract: An apparatus, and method, for a garment embedded secretion analysis. The system includes a liner that includes at least a sensor from a plurality of sensors. The system also includes a computing device embedded in the liner and communicatively connected to the at least a sensor, where the computing device includes a detection module configured to extract at least a biological sample from the user, authenticate the user as a function of the biological sample and a biological data of the user, detect a condition datum as a function of the biological sample and biological data of the user and determine an event datum as a function of the condition datum. Computing device also includes a safety module configured to receive the event datum and generate an alert datum as a function of the event datum.

Abstract: In one example a method of generating a three-dimensional object in a 3D printing system using a fusing agent of a first colour and a build material having a second colour different from the first colour, and a detailing agent, comprises obtaining object model data describing an object to be generated, and determining a first portion of the object to be generated to have the second colour. The method comprises determining object generation instructions to generate the object by defining a gap region of a layer of build material that is to correspond to the first portion of the object to have the second colour on which no agents are to be applied, a band of detailing agent on a layer of build material immediately adjacent to the gap region to define an outer limit of the gap region and therefore a boundary of the first portion of the object, and a fusing agent region on a layer of build material adjacent to the gap region on which fusing agent is to be applied.

Abstract: A device and method for real-time measurement using acoustic wave sensors, without the measurement being altered by environmental conditions such as temperature, humidity, flow or pressure, and without requiring the use of external gauges. The proposed method and device improve the stability and detection limit of quartz crystal microbalance (QCM) sensors. The method and device are based on the high degree of correlation between acoustic resonators integrated into a single piezoelectric substrate. The use of a reference sample to correct the instability of the baseline is not required. The method and device are intended for the industrial sector of the production of measuring devices based on quartz crystals.

Abstract: An online system receives, from a client device of a posting user, a script for a voice-based content item. The online system retrieves a voice synthesis model stored in the user profile of the posting user and generates a synthetic audio stream using the retrieved voice synthesis model and based on the received script. The online system presents the generated synthetic audio stream to the posting user and receives instructions for modifying the synthetic audio stream. The online system generates a second audio stream based on the received instructions and composes the voice-based tent item based on the generated second audio stream.

Abstract: Provided are methods for the treatment of SCLC patients by administering therapeutic amounts of lurbinectedin by intravenous infusion. Also provided are methods of treating cancer by administering lurbinectedin in combination with other anticancer drugs, in particular topoisomerase inhibitors. The invention further relates to the administration of lurbinectedin in combination with anti-emetic agents for effective control of symptoms related to nausea and vomiting, reduced lurbinectedin dosages to achieve a safer administration and an increase in the number of treatment cycles. Stable lyophilized formulations of lurbinectedin are also provided.

Abstract: Provided are methods for the treatment of SCLC patients by administering therapeutic amounts of lurbinectedin by intravenous infusion. Also provided are methods of treating cancer by administering lurbinectedin in combination with other anticancer drugs, in particular topoisomerase inhibitors. The invention further relates to the administration of lurbinectedin in combination with anti-emetic agents for effective control of symptoms related to nausea and vomiting, reduced lurbinectedin dosages to achieve a safer administration and an increase in the number of treatment cycles. Stable lyophilized formulations of lurbinectedin are also provided.

Abstract: Provided are methods for the treatment of SCLC patients by administering therapeutic amounts of lurbinectedin by intravenous infusion. Also provided are methods of treating cancer by administering lurbinectedin in combination with other anticancer drugs, in particular topoisomerase inhibitors. The invention further relates to the administration of lurbinectedin in combination with anti-emetic agents for effective control of symptoms related to nausea and vomiting, reduced lurbinectedin dosages to achieve a safer administration and an increase in the number of treatment cycles. Stable lyophilized formulations of lurbinectedin are also provided.

Abstract: The present disclosure provides a drug delivery device. The drug delivery device is taken orally by a patient, and then activates within the gastrointestinal (GI) tract of the patient. Upon activation, resilient arms within the drug delivery device expand and engage the GI tract walls. A driver then drives a plunger within the drug delivery device, pushing a drug through a channel in the resilient arms and through the GI tract walls of the patient. After a period of time, at least a portion of the drug delivery device dissolves and the drug delivery device passes through the GI tract.

Abstract: The present invention relates to the use of compounds in the treatment of inflammation, preferably inflammation associated with activation of Toll-like receptors. The invention also relates to the use of compounds to treat pathogen-induced inflammation.

Abstract: A platform is moved to translate contents of a print chamber to a secondary chamber. Negative pressure is applied to the secondary chamber and print chamber during motion of the platform, to reduce friction between the contents of the print chamber and sidewalls of the print chamber.

Abstract: The use of PLD with one or more further CoV antiviral agent(s) in the treatment of coronavirus (CoV) infection.

Abstract: The present invention relates to the use of compounds in the treatment of a viral infection, wherein the virus is selected from the Orthomyxoviridae family or wherein the virus is West Nile virus.

Abstract: A compound of general formula (I) wherein X, Y, n, p, q, and R1-R17 take various meanings, for use in the treatment of Coronavirus infection.

Abstract: The present invention relates to the use of compounds in the treatment of autoimmune conditions, and in particular, for the treatment of rheumatoid arthritis.

Abstract: Methods, systems, and computer-storage media are provided for a extracting real-time data to generate utilization models and reports for improving the utilization of a surgical block within a healthcare system. Sets of real-time data are extracted from a first source, a second source, and a third source. The sets of data are processed, validated, and transformed into a first set of utilization data. The first set of utilization data is analyzed and a utilization model is generated based on such analysis. Additionally, a report, which includes the utilization model, is generated for display to a user via a user interface. The use of the report and utilization model allow for implementing changes to scheduling and workflow that result in increasing surgical block utilization rates.

Abstract: Provided are methods for the treatment of SCLC patients by administering therapeutic amounts of lurbinectedin by intravenous infusion. Also provided are methods of treating cancer by administering lurbinectedin in combination with other anticancer drugs, in particular topoisomerase inhibitors. The invention further relates to the administration of lurbinectedin in combination with anti-emetic agents for effective control of symptoms related to nausea and vomiting, reduced lurbinectedin dosages to achieve a safer administration and an increase in the number of treatment cycles. Stable lyophilized formulations of lurbinectedin are also provided.

Abstract: A client device receives an arrangement of at least a subset of participants of a virtual meeting. The client device additionally receives an audio stream for each participant of the subset of participants of the virtual meeting. For each participant of the subset of participants, the client device determines a location based at least in part on the received arrangement, and modulates the received audio stream of the participant based on the determined location. The client device generates a combined modulated audio stream by combining the modulated audio stream of each of the participants and plays the combined modulated audio stream.

Abstract: A planar transformer including a planar first primary coil; a planar first secondary coil inductively coupled with the first primary coil; and a transformer magnetic core for guiding a magnetic flux generated by the first primary coil and/or the first secondary coil around at least a first opening of the transformer magnetic core. The first primary coil and the first secondary coil are coiled around the transformer magnetic core through the first opening. The first primary coil and the first secondary coil are arranged on a first plane. The embodiments further refer to a battery charger including such a planar transformer.